Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivacaftor observational study in cystic fibrosis patients with the S1251N gating mutation
NL-OMON41740Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ivacaftor in cystic fibrosis (CF), sponsored by University Medical Center Utrecht. Primary endpoint: Sweat chloride concentration. Started Dec 2014; status: active, not recruiting.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON41740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41740.